Hay DW[au] - Search Results

Year	Number of Results
1980	1
1982	3
1983	3
1984	1
1985	1
1986	8
1987	10
1988	3
1989	3
1990	5
1991	3
1992	5
1993	6
1994	3
1995	5
1996	8
1997	10
1998	9
1999	10
2000	11
2001	7
2002	2
2003	2
2004	2
2005	1
2006	1
2007	1
2008	1
2009	1
2010	1
2012	1
2013	2
2021	0

1

Interleukin-8 receptor antagonists in pulmonary diseases.

Hay DW, Sarau HM. Hay DW, et al. Curr Opin Pharmacol. 2001 Jun;1(3):242-7. doi: 10.1016/s1471-4892(01)00043-1. Curr Opin Pharmacol. 2001. PMID: 11712746 Review.

2

Is endothelin-1 a mediator in asthma?

Hay DW, Henry PJ, Goldie RG. Hay DW, et al. Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1594-7. doi: 10.1164/ajrccm.154.6.8970340. Am J Respir Crit Care Med. 1996. PMID: 8970340 Review.

3

Preface.

Battistini B, Goldie RG, Hay DWP. Battistini B, et al. Among authors: hay dwp. Pulm Pharmacol Ther. 1998 Apr;11(2-3):77-8. doi: 10.1006/pupt.1998.0146. Pulm Pharmacol Ther. 1998. PMID: 9918739 No abstract available.

4

Chemical species of lipids in bile.

Hay DW, Carey MC. Hay DW, et al. Hepatology. 1990 Sep;12(3 Pt 2):6S-14S; discussion 14S-16S. Hepatology. 1990. PMID: 2210659 Review.

5

International Union of Pharmacology XLIV. Nomenclature for the oxoeicosanoid receptor.

Brink C, Dahlén SE, Drazen J, Evans JF, Hay DW, Rovati GE, Serhan CN, Shimizu T, Yokomizo T. Brink C, et al. Among authors: hay dw. Pharmacol Rev. 2004 Mar;56(1):149-57. doi: 10.1124/pr.56.1.4. Pharmacol Rev. 2004. PMID: 15001665 Review.

6

Pharmacology of leukotriene receptor antagonists. More than inhibitors of bronchoconstriction.

Hay DW. Hay DW. Chest. 1997 Feb;111(2 Suppl):35S-45S. doi: 10.1378/chest.111.2_supplement.35s. Chest. 1997. PMID: 9042025 Review.

7

International Union of Pharmacology XXXVII. Nomenclature for leukotriene and lipoxin receptors.

Brink C, Dahlén SE, Drazen J, Evans JF, Hay DW, Nicosia S, Serhan CN, Shimizu T, Yokomizo T. Brink C, et al. Among authors: hay dw. Pharmacol Rev. 2003 Mar;55(1):195-227. doi: 10.1124/pr.55.1.8. Pharmacol Rev. 2003. PMID: 12615958 Review.

8

The lipoxin receptor ALX: potent ligand-specific and stereoselective actions in vivo.

Chiang N, Serhan CN, Dahlén SE, Drazen JM, Hay DW, Rovati GE, Shimizu T, Yokomizo T, Brink C. Chiang N, et al. Among authors: hay dw. Pharmacol Rev. 2006 Sep;58(3):463-87. doi: 10.1124/pr.58.3.4. Pharmacol Rev. 2006. PMID: 16968948 Review.

9

Cysteinyl leukotrienes in asthma: old mediators up to new tricks.

Hay DW, Torphy TJ, Undem BJ. Hay DW, et al. Trends Pharmacol Sci. 1995 Sep;16(9):304-9. doi: 10.1016/s0165-6147(00)89059-8. Trends Pharmacol Sci. 1995. PMID: 7482995 Review.

10

Endothelin and the respiratory system.

Hay DW, Henry PJ, Goldie RG. Hay DW, et al. Trends Pharmacol Sci. 1993 Jan;14(1):29-32. doi: 10.1016/0165-6147(93)90111-v. Trends Pharmacol Sci. 1993. PMID: 8442298 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results